Compass Course for Coronavirus

Phase-Based Progress Estimates
Coronavirus+4 MoreCompass Course - Behavioral
18 - 80
All Sexes
What conditions do you have?

Study Summary

This trial will help to assess whether the Compass Course is efficacious in helping individuals who were hospitalized with COVID-19 to reframe a sense of self and reaffirm or reconstruct a sense of purpose in their daily lives.

Eligible Conditions
  • Coronavirus

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: Will be assessed at baseline (week 0) and completion (following session 8, week 12)

Week 12
Change in Meaning in Life Questionnaire
Change in Psychological Wellbeing
Change in Purpose Status Question

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

Compass Course
1 of 1

Experimental Treatment

48 Total Participants · 1 Treatment Group

Primary Treatment: Compass Course · No Placebo Group · N/A

Compass Course
Experimental Group · 1 Intervention: Compass Course · Intervention Types: Behavioral
First Studied
Drug Approval Stage
How many patients have taken this drug
Compass Course

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: will be assessed at baseline (week 0) and completion (following session 8, week 12)

Who is running the clinical trial?

Allina Health SystemLead Sponsor
52 Previous Clinical Trials
1,174,456 Total Patients Enrolled
Mary V Radomski, OTR/L, PhDPrincipal InvestigatorAllina Health
1 Previous Clinical Trials
20 Total Patients Enrolled

Eligibility Criteria

Age 18 - 80 · All Participants · 10 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have access to a computer or tablet and adequate internet connection to participate in video conference.
You have an email address.
You agree to use your smartphone to download the mEMA application and respond to application notifications.